Targeting the Raf kinase cascade in cancer therapy--novel molecular targets and therapeutic strategies (Q35020561)

5 August 2017

1 reference

title

Targeting the Raf kinase cascade in cancer therapy--novel molecular targets and therapeutic strategies (English)

1 reference

5 August 2017

James A McCubrey

2

0 references

author name string

John T Lee

series ordinal

1

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Expert Opinion on Therapeutic Targets

5 August 2017

published in

1 reference

5 August 2017

volume

6

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

659-678

1 reference

The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Farnesyl transferase inhibitors: a novel targeted tnerapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

The p38 MAP kinase pathway and its biological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Molecular determinants that mediate selective activation of p38 MAP kinase isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

From receptors to stress-activated MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Ras/Raf signalling and emerging pharmacotherapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Signaling by the cytokine receptor superfamily: JAKs and STATs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Activation of Raf-1 by interferon gamma and oncostatin M requires expression of the Stat1 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Isotype-specific functions of Raf kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Kinases: positive and negative regulators of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Suppression of apoptosis: role in cell growth and neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Complex formation between RAS and RAF and other protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Mitogenic signaling of Ras is regulated by differential interaction with Raf isozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Kinase suppressor of Ras is ceramide-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Targeting protein kinase C: new therapeutic opportunities against high-grade malignant gliomas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

p21-activated kinases: three more join the Pak.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Phosphorylation site specificity of the Pak-mediated regulation of Raf-1 and cooperativity with Src.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

ERK2 enters the nucleus by a carrier-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

90-kDa ribosomal S6 kinase is phosphorylated and activated by 3-phosphoinositide-dependent protein kinase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

A distinct class of dominant negative Ras mutants: cytosolic GTP-bound Ras effector domain mutants that inhibit Ras signaling and transformation and enhance cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Competitive inhibition of MAP kinase activation by a peptide representing the alpha C helix of ERK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Farnesyltransferase inhibitors: mechanism and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Oligonucleotide treatment of ras-induced tumors in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

The heat shock protein 90 antagonist novobiocin interacts with a previously unrecognized ATP-binding domain in the carboxyl terminus of the chaperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Pharmacological inhibitors of MAPK pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

Ro 09-2210 exhibits potent anti-proliferative effects on activated T cells by selectively blocking MKK activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.6.659

21 January 2018

Identifiers

DOI

10.1517/14728222.6.6.659

1 reference

5 August 2017

1 reference